(Bloomberg) --
Bergman Clinics, a Dutch chain of medical clinics, is exploring a sale that could fetch as much as 1 billion euros ($1.1 billion), according to people familiar with the matter.
The company is working with JPMorgan Chase & Co. to gauge interest from potential buyers, the people said, asking not to be identified as the matter is private. The sale is likely to attract competitors as well as private equity firms, the people said.
Bergman runs private clinics focused on orthopedic care, eye treatments and skin care, with more than 50 locations in the Netherlands. Deliberations are at an early stage, and the discussions may not result in a deal, the people said.
Officials at Bergman and its private-equity backer, NPM Capital, couldn’t immediately be reached for comment. A representative for JPMorgan declined to comment.
Dealmaking involving medical services companies is heating up as buyout firms seek exposure to the fast-growing industry. French laboratory chain Inovie Group is exploring a sale that could it at 1 billion euros or more, Bloomberg News reported in September.
Apax Partners is weighing a sale of diagnostic services business Unilabs, while Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH, people with knowledge of the matter have said.
©2020 Bloomberg L.P.
RECOMMENDED FOR YOU
POPULAR